Publicité
Publicité
CMMB
Chemomab Therapeutics Ltd. - ADR
1.77
USDSponsorisé
-0.03
-1.39%
09 janv., 15:57 UTC -5
Fermé
Après-marché
1.86
+0.09
+4.79%
CMMB Rapports sur les bénéfices
Ratio de surprise positive
CMMB a dépassé 3 des 20 dernières estimations.
15%
Prochain rapport
Date du prochain rapport
02 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.01
Variation implicite de Q3 25 (Revenue/ EPS)
--
/--
Variation implicite de Q4 24 (Revenue/ EPS)
--
/-98.44%
Chemomab Therapeutics Ltd. - ADR earnings per share and revenue
On 17 nov. 2025, CMMB reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.01 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 3 analystes forecast an EPS of -0.01 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Chemomab Therapeutics Ltd. - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Chemomab Therapeutics Ltd. - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Chemomab Therapeutics Ltd. - ADR's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Chemomab Therapeutics Ltd. - ADR expected to report next?
The next earning report is scheduled for 02 mars 2026.
What are the forecasts for Chemomab Therapeutics Ltd. - ADR's next earnings report?
Based on 3
analystes, Chemomab Therapeutics Ltd. - ADR is expected to report EPS of -$0.01 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité